Alexion Pharmaceuticals, Inc.
(NASDAQ:ALXN)|
31.90 +0.88 (2.84%) Dec 04 - Close |
|
|
|
After-Hours 31.93 +0.03 (0.09%) Thu, 4 Dec 2008 7:40 PM
- Compare ALXN with:
- View: Line | Candlestick
Company Profile
Alexion Pharmaceuticals, Inc.
352 Knotter Drive
Cheshire, CT 06410
United States - Map
Phone: (203) 272-2596
Fax: (203) 271-8190
Website: www.alexionpharm.com
State of incorporation: Delaware
CEO: Dr. Leonard Bell, M.D.
Employees: 434
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Research-based biopharmaceutical company
A biopharmaceutical company, which is engaged in discovery, development & delivery of biologic therapeutic products to treat patients with severe & life-threatening disease states, including hematologic & neurologic diseases, cancer & autoi
Recent news for ALXN
-
Alexion to Present at the 20th Annual Piper Jaffray Health Care Conference
PR Newswire - Nov 25 at 10:00 ET
-
The Technical Indicator: U.S. markets teetering around five-year lows
MarketWatch - Nov 18 at 12:29 ET
-
EDGAR Online - Nov 12 at 9:15 ET
-
Alexion President, COO Keiser to retire
AP - Nov 11 at 10:55 ET
-
InPlay: Alexion Pharma reports that David Keiser to retire as President
Briefing.com - Nov 11 at 9:04 ET
-
David W. Keiser to Retire as President of Alexion
PR Newswire - Nov 11 at 9:00 ET
-
PR Newswire - Nov 10 at 1:10 ET
-
ALEXION PHARMACEUTICALS INC Financials
EDGAR Online Financials - Nov 05 at 9:04 ET
-
Biotechs Brew Up Strong Profits, Sales In Weak Economy
Investor's Business Daily - Nov 04 at 7:03 ET
-
Alexion to Present at Investor Conferences
PR Newswire - Nov 04 at 10:00 ET
